Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
ML111 (VU590 HCl)
AOB1540
CAS No: 1783987-83-6, 313505-85-0 (Free Base)
Chemical Name: 7,13-Bis[(4-nitrophenyl)methyl]-1,4
1000 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $16.15 | Total: $80.75 |
| 1 | 10 | $13.68 | Total: $136.80 |
| 1 | 25 | $11.59 | Total: $289.75 |
| 1 | 50 | $9.88 | Total: $494.00 |
| 1 | 100 | $8.55 | Total: $855.00 |
Overview
Inhibitor of ROMK and Kir7.1
Chemical Properties
| Molecular Formula | C24H32N4O7.2HCl |
| Molecular Weight | 561.46 |
| CAS Numbers | 1783987-83-6; 313505-85-0 (Free Base) |
| Solubility | 100 mM in DMSO |
| IUPAC/Chemical Name | 7,13-bis(4-nitrobenzyl)-1,4,10-trioxa-7,13-diazacyclopentadecane, dihydrochloride |
| InChl Key | FRYYSUBAHIUBNJ-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C24H32N4O7.2ClH/c29-27(30)23-5-1-21(2-6-23)19-25-9-13-33-14-10-26(12-16-35-18-17-34-15-11-25)20-22-3-7-24(8-4-22)28(31)32;;/h1-8H,9-20H2;2*1H |
| SMILES Code | O=[N+](C(C=C1)=CC=C1CN2CCOCCOCCN(CCOCC2)CC3=CC=C([N+]([O-])=O)C=C3)[O-].Cl.Cl |
Storage and Handling
-20°C
Synonyms
VU 590 2HCl
References
1) Hebert, S.C., Desir, G., Giebisch, G., et al. Molecular diversity and regulation of renal potassium channels. Physiol. Rev. 85(1), 319-371 (2005).
2) Edwards, A.O. Clinical features of the congenital vitreoretinopathies. Eye (Lond) 22(10), 1233-1242 (2008).